$PRCT
PROCEPT BioRobotics Corp Stock $prct

$prct Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000158897823000016 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$33.10M	$24.40M
YoY Change	98.33%	71.9%
Cost Of Revenue	$14.68M	$11.91M
YoY Change	78.85%	83.14%
Gross Profit	$18.43M	$12.49M
YoY Change	117.17%	62.39%
Gross Profit Margin	55.67%	51.18%
Selling, General & Admin	$32.44M	$30.13M
YoY Change	65.05%	63.89%
% of Gross Profit	176.03%	241.22%
Research & Development	$11.61M	$10.74M
YoY Change	73.17%	114.27%
% of Gross Profit	63.01%	85.96%
Depreciation & Amortization	$642.0K	$793.0K
YoY Change	-10.46%	4.62%
% of Gross Profit	3.48%	6.35%
Operating Expenses	$44.05M	$40.87M
YoY Change	67.12%	74.68%
Operating Profit	-$25.63M	-$28.38M
YoY Change	43.36%	80.7%
Interest Expense	$340.0K	$886.0K
YoY Change	-76.41%	-37.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$25.29M	-$28.48M
YoY Change	31.8%	65.75%
Income Tax
% Of Pretax Income
Net Earnings	-$25.29M	-$28.48M
YoY Change	31.8%	65.75%
Net Earnings / Revenue	-76.38%	-116.72%
Basic Earnings Per Share	-$0.56	-$0.63
Diluted Earnings Per Share	-$0.56	-$0.63
COMMON SHARES
Basic Shares Outstanding	45.05M shares	44.87M shares
Diluted Shares Outstanding	45.16M shares	45.07M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$149.7M	$181.0M
YoY Change	-44.52%	-36.34%
Cash & Equivalents	$149.7M	$181.0M
Short-Term Investments
Other Short-Term Assets	$4.516M	$5.040M
YoY Change	16.99%	42.74%
Inventory	$42.64M	$38.93M
Prepaid Expenses
Receivables	$33.17M	$20.64M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$230.0M	$245.6M
YoY Change	-22.9%	-20.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.36M	$11.93M
YoY Change	272.0%	161.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$131.0K	$51.00K
YoY Change	-56.62%	-98.66%
Total Long-Term Assets	$42.43M	$38.88M
YoY Change	237.01%	200.61%
TOTAL ASSETS
Total Short-Term Assets	$230.0M	$245.6M
Total Long-Term Assets	$42.43M	$38.88M
Total Assets	$272.4M	$284.5M
YoY Change	-12.38%	-11.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.04M	$10.34M
YoY Change	200.3%	293.49%
Accrued Expenses	$12.30M	$10.41M
YoY Change	34.25%	20.79%
Deferred Revenue	$4.717M	$3.943M
YoY Change	153.19%	188.23%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$35.95M	$32.50M
YoY Change	92.91%	120.26%
LONG-TERM LIABILITIES
Long-Term Debt	$51.28M	$51.24M
YoY Change	1.52%	1.96%
Other Long-Term Liabilities	$29.32M	$27.59M
YoY Change	14562.0%	13693.5%
Total Long-Term Liabilities	$51.28M	$51.24M
YoY Change	1.12%	1.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.95M	$32.50M
Total Long-Term Liabilities	$51.28M	$51.24M
Total Liabilities	$116.5M	$111.3M
YoY Change	62.46%	63.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$402.4M	-$377.2M
YoY Change	35.09%	35.33%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$155.9M	$173.1M
YoY Change
Total Liabilities & Shareholders Equity	$272.4M	$284.5M
YoY Change	-12.38%	-11.36%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$25.29M	-$28.48M
YoY Change	31.8%	65.75%
Depreciation, Depletion And Amortization	$642.0K	$793.0K
YoY Change	-10.46%	4.62%
Cash From Operating Activities	-$28.34M	-$35.93M
YoY Change	65.47%	97.07%
INVESTING ACTIVITIES
Capital Expenditures	$5.372M	$5.339M
YoY Change	-2564.22%	9607.27%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.372M	-$5.339M
YoY Change	2364.22%	9607.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.430M	$380.0K
YoY Change	-15.09%	-70.57%
NET CHANGE
Cash From Operating Activities	-28.34M	-$35.93M
Cash From Investing Activities	-5.372M	-$5.339M
Cash From Financing Activities	2.430M	$380.0K
Net Change In Cash	-31.28M	-$40.89M
YoY Change	116.0%	140.58%
FREE CASH FLOW
Cash From Operating Activities	-$28.34M	-$35.93M
Capital Expenditures	$5.372M	$5.339M
Free Cash Flow	-$33.71M	-$41.27M
YoY Change	99.38%	125.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001588978
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#DerivativeLiabilitiesNoncurrent
CY2023Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#DerivativeLiabilitiesNoncurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40797
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	PROCEPT BioRobotics Corporation
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0199180
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Island Drive
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94065
CY2023Q1	dei	City Area Code CityAreaCode	650
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	232-7200
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	PRCT
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45049157	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180972000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	221859000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	777000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	777000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20642000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15272000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	38926000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	28543000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4263000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6175000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	245580000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	272626000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3038000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3038000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11934000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8656000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22446000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23481000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1409000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1477000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000	usd
CY2023Q1	us-gaap	Assets Assets	284458000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23975000	usd
CY2022Q4	us-gaap	Assets Assets	309329000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10341000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9391000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7408000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13447000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3943000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2855000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2998000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2129000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7814000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7468000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32504000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35290000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	51241000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	51213000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25782000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1805000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1779000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	111332000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	112257000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45009000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45009000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44828000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44828000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	550270000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	545753000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-377159000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-348675000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	173126000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	197072000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	284458000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	309329000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24404000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14197000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	11913000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	6505000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	12491000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	7692000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10737000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5011000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30131000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18385000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	40868000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	23396000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28377000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15704000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	886000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1421000	usd
CY2023Q1	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	779000	usd
CY2022Q1	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	-60000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28484000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45066000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45066000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43855000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43855000	shares
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	21000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28463000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17184000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	197072000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	380000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	4137000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	21000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28484000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	173126000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	267091000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1291000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1552000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	252750000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28484000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	793000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	758000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3724000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1552000	usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	26000	usd
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	37000	usd
CY2023Q1	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	-495000	usd
CY2022Q1	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	97000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	228000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5370000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2529000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10136000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-517000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1931000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-177000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2225000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	448000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-6039000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-1889000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	28000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	250000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1088000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	343000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3217000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	346000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-613000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35928000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18231000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5339000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5339000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	380000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1291000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	380000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1291000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-40887000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16995000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225674000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305097000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184787000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	288102000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180972000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	284288000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3815000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3814000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184787000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	288102000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1121000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1171000	usd
CY2023Q1	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	-62000	usd
CY2022Q1	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	0	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2269000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	351000	usd
CY2023Q1	prct	Number Of Men Impacted By Benign Prostatic Hyperplasia NumberOfMenImpactedByBenignProstaticHyperplasia	40000000	customer
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2846000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its stock-based compensation expense, right-of-use lease asset, lease liability, loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	15663000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12417000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1738000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	20417000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14388000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	38926000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	28543000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21649000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17660000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9715000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9004000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11934000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8656000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	84600000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	126300000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	115000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	185300000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2300000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8700000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	14900000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4137000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1552000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28484000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17185000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45066000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45066000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43855000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43855000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7097000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6414000	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24404000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14197000	usd
CY2021Q4	prct	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	renewaloption
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	2000000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4615000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	4615000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4183000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	4183000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4297000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4333000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	8630000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4426000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	26000000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Year Three OperatingLeaseLiabilityAndLongTermDebtMaturityYearThree	30426000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4808000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	21667000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Year Four OperatingLeaseLiabilityAndLongTermDebtMaturityYearFour	26475000	usd
CY2023Q1	prct	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	27250000	usd
CY2023Q1	prct	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Thereafter OperatingLeaseLiabilityAndLongTermDebtMaturityThereafter	27250000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	49579000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	52000000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	101579000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20799000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	759000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	21558000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	28780000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	51241000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	80021000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2998000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	2998000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25782000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	51241000	usd
CY2023Q1	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	77023000	usd
CY2023Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	500000	usd
CY2022Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	usd

Files In Submission

Name	View Source	Status
prct-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001588978-23-000016-index-headers.html	Edgar Link	pending
0001588978-23-000016-index.html	Edgar Link	pending
0001588978-23-000016.txt	Edgar Link	pending
0001588978-23-000016-xbrl.zip	Edgar Link	pending
exhibit1018-nouriofferlett.htm	Edgar Link	pending
exhibit1019-nourichangeofc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prct-20230331.htm	Edgar Link	pending
prct-20230331.xsd	Edgar Link	pending
prct-ex311soxcertification.htm	Edgar Link	pending
prct-ex312soxcertification.htm	Edgar Link	pending
prct-ex321soxcertification.htm	Edgar Link	pending
prct-ex322soxcertification.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
prct-20230331_cal.xml	Edgar Link	unprocessable
prct-20230331_def.xml	Edgar Link	unprocessable
prct-20230331_pre.xml	Edgar Link	unprocessable
prct-20230331_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRCT
PROCEPT BioRobotics Corp Stock $prct

2023 Q2 Form 10-Q Financial Statement

#000158897823000016 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT PROCEPT BioRobotics Corp Stock $prct

2023 Q2 Form 10-Q Financial Statement

#000158897823000016 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT
PROCEPT BioRobotics Corp Stock $prct